NeOnc Technologies Appoints Jimmy Delshad, Bader Almonawer to Board

NeOnc Technologies Holdings, Inc. has recently appointed two new members to its Board of Directors, enhancing its management and financial expertise as it prepares to go public. The Honorable Jimmy Delshad, a former mayor of Beverly Hills and global ambassador for Cedars Sinai International, brings over 20 years of consulting experience to the team, aiming to support the company's mission in treating brain and Central Nervous System diseases. Meanwhile, Bader Almonawer, a seasoned financial expert with a background in venture capital and M&A, is expected to leverage his experience from McKinsey and the World Bank to guide NeOnc through its public company transition. Both appointments are seen as crucial to advancing NeOnc's innovative approach to addressing high unmet medical needs. This strategic enhancement of leadership comes as NeOnc looks to solidify its position in the biotech industry. Dr. Thomas Chen, CEO of NeOnc, expressed confidence that the new board members will significantly contribute to the company's growth and mission.